These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32216971)

  • 1. Acute Myocardial Infarction Due to Antiphospholipid Syndrome - Case Report and Review of the Literature.
    Semczuk-Kaczmarek K; Platek AE; Ryś-Czaporowska A; Szymanski FM; Filipiak KJ
    Curr Probl Cardiol; 2021 Mar; 46(3):100552. PubMed ID: 32216971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties.
    Lóczi L; Kappelmayer J; Tarr T; Bagoly Z
    Kardiol Pol; 2020 Jan; 78(1):6-14. PubMed ID: 31808421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
    Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
    Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic antiphospholipid syndrome: From guidelines to clinical management.
    Paredes-Ruiz D; Martin-Iglesias D; Ruiz-Irastorza G
    Med Clin (Barc); 2024 Aug; 163 Suppl 1():S22-S30. PubMed ID: 39174150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins.
    Djokovic A; Stojanovich L; Stanisavljevic N; Popovic M; Zdravkovic M
    Lupus; 2020 Apr; 29(5):505-508. PubMed ID: 32041501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Isenberg DA
    Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Disease in Antiphospholipid Syndrome.
    Polytarchou K; Varvarousis D; Manolis AS
    Curr Vasc Pharmacol; 2020; 18(6):538-548. PubMed ID: 31530257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].
    van Mens TE; Middeldorp S; Coppens M
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
    Cohen H; Efthymiou M; Devreese KMJ
    J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.
    Islabão AG; Trindade VC; da Mota LMH; Andrade DCO; Silva CA
    Paediatr Drugs; 2022 Jan; 24(1):13-27. PubMed ID: 34904182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute anterior myocardial infarction as presenting feature of antiphospholipid syndrome related lupus arthritis].
    Capilla-Geay E; Poyet R; Brocq FX; Pons F; Kerebel S; Foucault G; Jego C; Cellarier GR
    Rev Med Interne; 2016 May; 37(5):371-4. PubMed ID: 26363818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature.
    Marco-Rico A; Marco-Vera P
    Semin Thromb Hemost; 2023 Oct; 49(7):736-743. PubMed ID: 36996874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Zuily S; Cohen H; Isenberg D; Woller SC; Crowther M; Dufrost V; Wahl D; Doré CJ; Cuker A; Carrier M; Pengo V; Devreese KMJ
    J Thromb Haemost; 2020 Sep; 18(9):2126-2137. PubMed ID: 32881337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome.
    González-Pacheco H; Eid-Lidt G; Piña-Reyna Y; Amezcua-Guerra LM; Aldana-Sepúlveda N; Martínez-Sánchez C
    Am J Emerg Med; 2014 Feb; 32(2):197.e3-5. PubMed ID: 24176588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary thrombosis as the first complication of antiphospholipid syndrome.
    Miranda CH; Gali LG; Marin-Neto JA; Louzada-Júnior P; Pazin-Filho A
    Arq Bras Cardiol; 2012 Apr; 98(4):e66-9. PubMed ID: 22735914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
    Schaefer JK; McBane RD; Black DF; Williams LN; Moder KG; Wysokinski WE
    Thromb Haemost; 2014 Nov; 112(5):947-50. PubMed ID: 25118790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
    Anderson M; Belmont HM
    Lupus; 2022 Feb; 31(2):261-267. PubMed ID: 35041558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.